Detalles de la búsqueda
1.
Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
Psychol Med
; 53(9): 3783-3792, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37278215
2.
Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
PLoS Med
; 18(6): e1003664, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34111122
3.
Neuroimaging Association Scores: reliability and validity of aggregate measures of brain structural features linked to mental disorders in youth.
Eur Child Adolesc Psychiatry
; 30(12): 1895-1906, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33030612
4.
Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis.
BMJ Ment Health
; 26(1)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142305
5.
Disruptive Mood Dysregulation Disorder: Symptomatic and Syndromic Thresholds and Diagnostic Operationalization.
J Am Acad Child Adolesc Psychiatry
; 60(2): 286-295, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32004697
6.
Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents.
Neurobiol Aging
; 82: 10-17, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31376729
7.
Pediatric anxiety disorders: from neuroscience to evidence-based clinical practice.
Braz J Psychiatry
; 35 Suppl 1: S03-21, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24142122
8.
Pediatric anxiety disorders: from neuroscience to evidence-based clinical practice
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
; 35(supl.1): S03-S21, 2013. tab, graf
Artículo
en Inglés
| LILACS | ID: lil-687956
Resultados
1 -
8
de 8
1
Próxima >
>>